MarketInOut Stock Screener Log In | Sign Up

NGL Fine-Chem Ltd

BSE • Healthcare • Drug Manufacturers - General • Quote as of 10/27/2026 15:51
NGL Fine-Chem Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeBSE
Market Capitalization16,316 mln
Float1.68 mln

EPS

92.59
Exceptional

P / E

28.35
Elevated

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.24
Borderline

Relative Strength

25 / 100
Underperforming

Debt / Equity

0.37
Low leverage

Business Description

NGL Fine-Chem Limited is a Mumbai-based company founded in 1981 that produces active pharmaceutical ingredients, specialty chemicals, and finished drug products for both animal and human health markets. The company sells its products across India as well as in Europe, the Asia Pacific region, and the United States. Its portfolio covers a wide range of treatments, from veterinary antiparasitic and anti-infective compounds to human health ingredients used in fighting infections.

Key Fundamentals

EPS92.59
P/E28.35
ROE18.82
RPS867
ROIC12.96
ROA11.72
Interest Cover15.04
EBITDA, mln1,007
EV / EBITDA18.42
EV / EBIT23.15
Revenue, mln5,362
EV / Revenue3.46

Quote Details

Last 2,625.00
Change 8 (0.31%)
Open 2,673.85
Volume 17
Turnover 44,625
Average Volume 558.62

Financial Ratios

Pre-Tax Profit Margin14
Current Ratio1.84
Price / Book5.46
Price / Tangible Book5.46
Price / Cash Flow97.83
Debt / Equity0.37
Price / Sales3.35

Financial Strength

Altman Z-Score7.51
Piotroski F-Score 6 / 9
Beneish M-Score-2.24
Price to Graham Number3.01
Shiller PE Ratio47.97

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.9% 40 / 100   
1 Month -8.79% 42 / 100   
2 Months -12.41% 38 / 100   
6 Months 17.96% 80 / 100   
1 Year 74% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog